Literature DB >> 18082848

The endogenous OFQ/N/ORL-1 receptor system regulates the rewarding effects of acute cocaine.

Paul Marquez1, Alexander T Nguyen, Abdul Hamid, Kabirullah Lutfy.   

Abstract

Previous studies have shown that orphanin FQ/nociceptin (OFQ/N), the endogenous ligand of the opioid receptor-like (ORL-1) receptor, reduces the rewarding and addictive properties of cocaine and other drugs of abuse. In the present study, using the conditioned place preference (CPP) paradigm, as an animal model of drug reward, we assessed whether the rewarding action of acute cocaine would be altered in mice lacking the ORL-1 receptor or in wild type mice treated with J-113397, an ORL-1 receptor antagonist, relative to their saline-treated controls. On day 1, mice were tested for their baseline place preferences, in which each mouse was placed in the neutral chamber of a three-chambered CPP apparatus, allowed to freely explore all the chambers and the amount of time that a mouse spent in each conditioning chamber was recorded for 15 min. On days 2-3, mice received once daily alternate-day saline/cocaine (15 or 30 mg/kg) conditioning for 30 min. On day 4, mice were tested for their postconditioning preferences, as described for day 1. In a subsequent study, the effect of J-113397 (3 mg/kg) on the rewarding action of acute cocaine (15 mg/kg) was also examined in wild type mice. Our results showed that mice lacking the ORL-1 receptor expressed greater CPP than their wild type littermates. Furthermore, the rewarding action of cocaine was enhanced in the presence of J-113397 in wild type mice. Together, the present results suggest that the endogenous OFQ/N/ORL-1 receptor system is involved in the rewarding action of acute cocaine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18082848      PMCID: PMC2276976          DOI: 10.1016/j.neuropharm.2007.11.003

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  26 in total

1.  Discovery of the first potent and selective small molecule opioid receptor-like (ORL1) antagonist: 1-[(3R,4R)-1-cyclooctylmethyl-3- hydroxymethyl-4-piperidyl]-3-ethyl-1, 3-dihydro-2H-benzimidazol-2-one (J-113397).

Authors:  H Kawamoto; S Ozaki; Y Itoh; M Miyaji; S Arai; H Nakashima; T Kato; H Ohta; Y Iwasawa
Journal:  J Med Chem       Date:  1999-12-16       Impact factor: 7.446

2.  Orphanin FQ/nociceptin blocks cocaine-induced behavioral sensitization in rats.

Authors:  Kabirullah Lutfy; Imran Khaliq; F Ivy Carroll; Nigel T Maidment
Journal:  Psychopharmacology (Berl)       Date:  2002-08-30       Impact factor: 4.530

3.  Orphanin FQ/nociceptin attenuates motor stimulation and changes in nucleus accumbens extracellular dopamine induced by cocaine in rats.

Authors:  K Lutfy; T Do; N T Maidment
Journal:  Psychopharmacology (Berl)       Date:  2001-02       Impact factor: 4.530

4.  Effect of nociceptin/orphanin FQ on the rewarding properties of morphine.

Authors:  R Ciccocioppo; S Angeletti; P P Sanna; F Weiss; M Massi
Journal:  Eur J Pharmacol       Date:  2000-09-15       Impact factor: 4.432

Review 5.  The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family.

Authors:  J S Mogil; G W Pasternak
Journal:  Pharmacol Rev       Date:  2001-09       Impact factor: 25.468

6.  Nociceptin/orphanin FQ and opioid receptor-like receptor mRNA expression in dopamine systems.

Authors:  Camille S Norton; Charles R Neal; Suneel Kumar; Huda Akil; Stanley J Watson
Journal:  J Comp Neurol       Date:  2002-03-18       Impact factor: 3.215

7.  Orphanin FQ/nociceptin but not Ro 65-6570 inhibits the expression of cocaine-induced conditioned place preference.

Authors:  J Kotlińska; J Wichmann; A Legowska; K Rolka; J Silberring
Journal:  Behav Pharmacol       Date:  2002-05       Impact factor: 2.293

8.  Actions of orphanin FQ/nociceptin on rat ventral tegmental area neurons in vitro.

Authors:  Fang Zheng; David K Grandy; Steven W Johnson
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

9.  Nociceptin inhibits acquisition of amphetamine-induced place preference and sensitization to stereotypy in rats.

Authors:  Jolanta Kotlinska; Piotr Rafalski; Grazyna Biala; Tomasz Dylag; Krzysztof Rolka; Jerzy Silberring
Journal:  Eur J Pharmacol       Date:  2003-08-08       Impact factor: 4.432

10.  Rat ventral midbrain dopamine neurons express the orphanin FQ/nociceptin receptor ORL-1.

Authors:  Nigel T Maidment; Yiling Chen; Aiko M Tan; Niall P Murphy; Frances M Leslie
Journal:  Neuroreport       Date:  2002-07-02       Impact factor: 1.837

View more
  22 in total

1.  The first universal opioid ligand, (2S)-2-[(5R,6R,7R,14S)-N-cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydroxy-6-methoxymorphinan-7-yl]-3,3-dimethylpentan-2-ol (BU08028): characterization of the in vitro profile and in vivo behavioral effects in mouse models of acute pain and cocaine-induced reward.

Authors:  Taline V Khroyan; Willma E Polgar; Gerta Cami-Kobeci; Stephen M Husbands; Nurulain T Zaveri; Lawrence Toll
Journal:  J Pharmacol Exp Ther       Date:  2010-12-21       Impact factor: 4.030

2.  Buprenorphine requires concomitant activation of NOP and MOP receptors to reduce cocaine consumption.

Authors:  Marsida Kallupi; Qianwei Shen; Giordano de Guglielmo; Dennis Yasuda; V Blair Journigan; Nurulain T Zaveri; Roberto Ciccocioppo
Journal:  Addict Biol       Date:  2017-06-21       Impact factor: 4.280

3.  Nociceptin receptor activation does not alter acquisition, expression, extinction and reinstatement of conditioned cocaine preference in mice.

Authors:  G C Sartor; S K Powell; H J Wiedner; C Wahlestedt; S P Brothers
Journal:  Brain Res       Date:  2015-12-03       Impact factor: 3.252

Review 4.  Estradiol: a key biological substrate mediating the response to cocaine in female rats.

Authors:  Annabell C Segarra; José L Agosto-Rivera; Marcelo Febo; Natasha Lugo-Escobar; Raissa Menéndez-Delmestre; Anabel Puig-Ramos; Yvonne M Torres-Diaz
Journal:  Horm Behav       Date:  2009-12-21       Impact factor: 3.587

Review 5.  The nociceptin/orphanin FQ receptor (NOP) as a target for drug abuse medications.

Authors:  Nurulain T Zaveri
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

6.  Nociceptin Receptors Upregulated in Cocaine Use Disorder: A Positron Emission Tomography Imaging Study Using [11C]NOP-1A.

Authors:  Rajesh Narendran; Savannah Tollefson; Michael L Himes; Jennifer Paris; Brian Lopresti; Roberto Ciccocioppo; N Scott Mason
Journal:  Am J Psychiatry       Date:  2019-05-06       Impact factor: 18.112

7.  Genetic Deletion of the Nociceptin/Orphanin FQ Receptor in the Rat Confers Resilience to the Development of Drug Addiction.

Authors:  Marsida Kallupi; Giulia Scuppa; Giordano de Guglielmo; Girolamo Calò; Friedbert Weiss; Michael A Statnick; Linda M Rorick-Kehn; Roberto Ciccocioppo
Journal:  Neuropsychopharmacology       Date:  2016-08-26       Impact factor: 7.853

Review 8.  Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems.

Authors:  Lawrence Toll; Michael R Bruchas; Girolamo Calo'; Brian M Cox; Nurulain T Zaveri
Journal:  Pharmacol Rev       Date:  2016-03-08       Impact factor: 25.468

9.  Novel role of the nociceptin system as a regulator of glutamate transporter expression in developing astrocytes.

Authors:  Logan C Meyer; Caitlin E Paisley; Esraa Mohamed; John W Bigbee; Tomasz Kordula; Hope Richard; Kabirullah Lutfy; Carmen Sato-Bigbee
Journal:  Glia       Date:  2017-09-14       Impact factor: 7.452

10.  The role of NOP receptors in psychomotor stimulation and locomotor sensitization induced by cocaine and amphetamine in mice.

Authors:  Paul Marquez; Abdul Hamid; Kabirullah Lutfy
Journal:  Eur J Pharmacol       Date:  2013-03-21       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.